Yuan Gao

Yuan Gao

Auto-generated profile, based on publicly available information

Yuan Gao

Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YGYuan Gao
Yuan Gao
SVSofia Ventura-Diaz
Sofia Ventura-Diaz
XWXin Wang
Xin Wang
MHMuzhen He
Muzhen He
ZXZeyan Xu
Zeyan Xu
RMRitse Mann
Ritse Mann
Multi-modal image analysis using deep learning (DL) lays the foundation for neoadjuvant treatment (NAT) response monitoring. However, existing methods prioritize extracting multi-modal features to enhance predictive performance, with limited consideration on real-world clinical applicability, particularly in longitudinal NAT scenarios with multi-modal data. Here, we propose the Multi-modal Response Prediction (MRP) system, designed to mimic real-world physician assessments of NAT responses in breast cancer. To enhance feasibility, MRP integrates cross-modal knowledge mining and temporal information embedding strategy to handle missing modalities and remain less affected by different NAT settings. We validated MRP through multi-center studies and multinational reader studies. MRP exhibited comparable robustness to breast radiologists, outperforming humans in predicting pathological complete response in the Pre-NAT phase (ΔAUROC 14% and 10% on in-house and external datasets, respectively). Furthermore, we assessed MRP’s clinical utility impact on treatment decision-making. MRP may have profound implications for enrolment into NAT trials and determining surgery extensiveness.

22 March 2023 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
TZTianyu Zhang
Tianyu Zhang
Tao TanTao Tan
Tao Tan
LHLuyi Han
Luyi Han
LALinda Appelman
Linda Appelman
JVJeroen Veltman
Jeroen Veltman
RMRitse M. Mann
Ritse M. Mann
Accurately determining the molecular subtypes of breast cancer is important for the prognosis of breast cancer patients and can guide treatment selection. In this study, we develop a deep learning-based model for predicting the molecular subtypes of breast cancer directly from the diagnostic mammography and ultrasound images. Multi-modal deep learning with intra- and inter-modality attention modules (MDL-IIA) is proposed to extract important relations between mammography and ultrasound for this task. MDL-IIA leads to the best diagnostic performance compared to other cohort models in predicting 4-category molecular subtypes with Matthews correlation coefficient (MCC) of 0.837 (95% confidence interval [CI]: 0.803, 0.870). The MDL-IIA model can also discriminate between Luminal and Non-Luminal disease with an area under the receiver operating characteristic curve of 0.929 (95% CI: 0.903, 0.951). These results significantly outperform clinicians’ predictions based on radiographic imaging. Beyond molecular-level test, based on gene-level ground truth, our method can bypass the inherent uncertainty from immunohistochemistry test. This work thus provides a noninvasive method to predict the molecular subtypes of breast cancer, potentially guiding treatment selection for breast cancer patients and providing decision support for clinicians.

11 February 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
YGYuan Gao
Yuan Gao
Tao TanTao Tan
Tao Tan
XWXin Wang
Xin Wang
RBRegina Beets-Tan
Regina Beets-Tan
TZTianyu Zhang
Tianyu Zhang
RMRitse Mann
Ritse Mann
Longitudinal medical imaging is crucial for monitoring neoadjuvant therapy (NAT) response in clinical practice. However, mainstream artificial intelligence (AI) methods for disease monitoring commonly rely on extensive segmentation labels to evaluate lesion progression. While self-supervised vision-language (VL) learning efficiently captures medical knowledge from radiology reports, existing methods focus on single time points, missing opportunities to leverage temporal self-supervision for disease progression tracking. In addition, extracting dynamic progression from longitudinal unannotated images with corresponding textual data poses challenges. In this work, we explicitly account for longitudinal NAT examinations and accompanying reports, encompassing scans before NAT and follow-up scans during mid-/post-NAT. We introduce the multi-modal longitudinal representation learning pipeline (MLRL), a temporal foundation model, that employs multi-scale self-supervision scheme, including single-time scale vision-text alignment (VTA) learning and multi-time scale visual/textual progress (TVP/TTP) learning to extract temporal representations from each modality, thereby facilitates the downstream evaluation of tumor progress. Our method is evaluated against several state-of-the-art self-supervised longitudinal learning and multi-modal VL methods. Results from internal and external datasets demonstrate that our approach not only enhances label efficiency across the zero-, few- and full-shot regime experiments but also significantly improves tumor response prediction in diverse treatment scenarios. Furthermore, MLRL enables interpretable visual tracking of progressive areas in temporal examinations, offering insights into longitudinal VL foundation tools and potentially facilitating the temporal clinical decision-making process.

29 October 2025 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
XWXin Wang
Xin Wang
Tao TanTao Tan
Tao Tan
YGYuan Gao
Yuan Gao
RSRuisheng Su
Ruisheng Su
JTJonas Teuwen
Jonas Teuwen
RMRitse Mann
Ritse Mann
Breast cancer (BC) risk assessment aims to enhance individualized screening and prevention strategies. While recent deep learning (DL) models based on mammography have shown promise in short-term risk prediction, they primarily rely on single-time-point (STP) exams, ignoring temporal changes in breast tissue from sequence exams. We present the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), a novel DL approach that integrates traditional risk factors and longitudinal mammography data to capture subtle tissue changes indicative of future malignancy. Using a large in-house dataset with 171,168 mammograms from 9133 women, MTP-BCR achieved superior performance in 10-year risk prediction, with an AUC of 0.80 (95% CI, 0.78–0.82) at the patient level, outperforming STP-based and traditional risk models. External validation on the CSAW-CC dataset confirmed its robustness. Further analysis demonstrates the advantages of the MTP-BCR method in diverse populations. MTP-BCR also excels in risk stratification and offers heatmaps to enhance clinical interpretability.

27 September 2023 in Research Square
Verified
Preprint
Open access
PDF file
Tao TanTao Tan
Tao Tan
XWXin Wang
Xin Wang
YGYuan Gao
Yuan Gao
RSRuisheng Su
Ruisheng Su
TZTianyu Zhang
Tianyu Zhang
RMRitse Mann
Ritse Mann
Risk assessment of breast cancer (BC) seeks to enhance individualized screening and prevention strategies. Recent deep learning (DL) risk models based on mammography have shown superiority in short-term risk prediction compared to traditional risk factor-based models. However, these models primarily rely on single-time exams, which emphasize the detection of existing lesions and may ignore the temporal changes in breast tissues. In this study, we present the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), a novel temporospatial DL risk model that integrates traditional BC risk factors and longitudinal mammography data to identify subtle changes in breast tissue indicative of future malignancy. Utilizing a large inhouse dataset comprising risk factors and 171,168 mammograms involving 9,133 women, we evaluate the performance of the MTP-BCR model in long-term risk prediction. Our model demonstrates a significant improvement in 10-year risk prediction with an area under the receiver operating characteristics (AUC) of 0.80, outperforming the traditional BCSC 10-year risk model, our pure image model (without risk factors), and is also superior to other SOTA methods at 5-year AUC in various screening cohorts. Furthermore, MTP-BCR provides unilateral breast-level predictions with AUCs up to 0.81 and 0.77 for 5-year and 10-year risk assessments, respectively. External validation in the public CSAW-CC dataset demonstrates the consistent advantage of our multi-time point-based model compared to the single-time point-based method. For the prediction of breast cancer recurrence, our MTP-BCR obtains a 5-year AUC of 0.71 which also surpasses other methods. The heatmaps derived from our model may help clinicians better understand the progression from normal tissue to cancerous growth, enhancing interpretability in breast cancer risk assessment.

16 February 2026 in Medical Image Analysis
Verified
Journal Article
Closed access
XWXin Wang
Xin Wang
Tao TanTao Tan
Tao Tan
YGYuan Gao
Yuan Gao
EMEric Marcus
Eric Marcus
HZHong-Yu Zhou
Hong-Yu Zhou
JTJonas Teuwen
Jonas Teuwen